OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B

OpenAI researcher Miles Wang is planning to start an AI-driven drug discovery company valued at $2 billion. Sources say venture firm Lightspeed is in talks to lead the funding round.

Summary written by Kernelia from the original article by TechCrunch AI. The story and its rights belong to its author.